ConductScience.org, home

Trial · NCT07504276

Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.

NCT07504276, Not applicable, Recruiting, Riphah International University

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. Trials, record NCT07504276. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07504276

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.
NCT number
NCT07504276
Status
Recruiting
Phases
Not applicable
Enrollment
32 participants, estimated
Lead sponsor
Riphah International University
Conditions
Stroke, Cognitive Impairment, Post-Stroke Cognitive Impairment
Interventions
Tele-rehabilitation, Conventional Rehabilitation
First posted
2026-03-31
Last updated
2026-04-03

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Cognitive Function Measured by Montreal Cognitive Assessment (MoCA)Baseline
The Montreal Cognitive Assessment (MoCA) will be used to assess global cognitive function, including attention, memory, executive function, language, and visuospatial abilities. Scores range from 0 to 30, with higher scores indicating better cognitive function.
PrimaryChange in Cognitive Function Measured by Montreal Cognitive Assessment (MoCA)After 8 weeks
The Montreal Cognitive Assessment (MoCA) will be used to assess global cognitive function, including attention, memory, executive function, language, and visuospatial abilities. Scores range from 0 to 30, with higher scores indicating better cognitive function.
SecondaryChange in Executive Function Measured by stroop TestBaselineThe Stroop test will be used to assess selective attention, cognitive flexibility, and inhibitory control. Performance will be evaluated based on completion time and error rate.
SecondaryChange in Executive Function Measured by stroop TestAfter 8 weeksThe Stroop test will be used to assess selective attention, cognitive flexibility, and inhibitory control. Performance will be evaluated based on completion time and error rate.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed as
Stroop Color-Word TestSecondary outcome

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07504276

GET https://conductscience.org/api/trials/v1/NCT07504276/registered